Cervical cancer is rapidly emerging as a significant public health concern in Canada, with health advocates urging the federal government to intensify efforts to combat this “silent national health crisis.” A recent press conference held by the Society of Gynecologic Oncology of Canada in Ottawa highlighted alarming statistics and underscored the need for immediate action, particularly in light of the government’s pledge to eliminate cervical cancer as a public health issue by 2040.
A Growing Concern
Dr. Shannon Salvador, the president of the Society of Gynecologic Oncology of Canada, addressed the pressing situation on Wednesday, stating, “Canada is currently serving a silent national health crisis.” In 2025 alone, around 1,650 Canadians were expected to receive a cervical cancer diagnosis, with approximately 430 succumbing to the disease—numbers that Dr. Salvador deemed “avoidable.”
Despite advancements in medical technology, the reliance on Pap tests and the stagnation of human papillomavirus (HPV) vaccination rates are major hurdles in tackling this preventable cancer. Currently, Canada’s HPV vaccination completion rate stands at a concerning 64 per cent, falling short of the targets necessary for effective elimination. Dr. Salvador emphasised, “This statistic is not merely a medical failure; it is a policy failure.”
Recommendations for Change
In response to the stagnation in screening and prevention efforts, the Society of Gynecologic Oncology of Canada is advocating for significant changes in cervical cancer screening protocols. They propose an immediate nationwide transition to HPV DNA testing and the introduction of self-collection kits, which could facilitate easier access to screening for individuals across the country.
The Canadian Cancer Society elaborated on these methods, indicating that HPV testing can be performed using a swab to collect cells from either the cervix or the vagina. Self-administered tests, where individuals can collect samples from home, represent a vital step towards enhancing accessibility. Dr. Salvador highlighted that these kits can help remove barriers related to travel, trauma history, and the ongoing lack of family doctors, particularly affecting rural, Indigenous, and marginalised communities.
Disparities in Health Outcomes
The conversation surrounding cervical cancer also illuminated significant disparities in health outcomes, particularly for Indigenous women. Dr. Sarah Kean, provincial lead for cervical cancer in Manitoba, noted that Indigenous women face higher diagnosis rates, often at more advanced stages, and endure poorer outcomes. She attributed these challenges to systemic barriers that include geographic isolation, lack of access to screening resources, and ongoing systemic racism within healthcare.
Dr. Kean called for “robust, accessible HPV screening across Canada,” insisting that federal legislation is essential to support this initiative. She asserted that true progress requires universal access to primary HPV testing across all provinces and territories, alongside clear national standards.
Financial Implications
The financial burden of cervical cancer on the Canadian healthcare system is also worrisome. In 2024, the costs associated with treating cervical cancer were estimated at approximately £132 million. In contrast, the projected expense for screening eligible Canadians over the next five years is about £106 million. These figures illustrate the economic rationale for investing in preventative measures rather than allowing the situation to deteriorate further.
The Bigger Picture
Despite a global push led by the World Health Organization (WHO) to eradicate cervical cancer, Canada’s progress appears to have stalled. According to a report from the Canadian Cancer Society, the incidence of cervical cancer is projected to remain static. While the rates of other cancers are decreasing, cervical cancer remains a significant health challenge, with 1,600 new diagnoses expected in 2024 and 400 deaths resulting from the disease.
Dr. Kean stressed the pivotal role of vaccination, HPV-based DNA screening, and access to treatment in achieving the goal of elimination. “All other cancers in our country are decreasing in incidence except for the one that is entirely preventable,” she lamented, highlighting the urgent need for comprehensive action.
Why it Matters
The rising incidence of cervical cancer represents not just a health crisis but a systemic failure that calls for immediate and concerted action from policymakers. With the potential for cervical cancer to be entirely preventable through effective screening and vaccination strategies, the current complacency is unacceptable. Addressing these health disparities and investing in robust screening programmes is crucial not only for saving lives but also for fostering a more equitable healthcare system for all Canadians. The time for action is now—our collective health depends on it.
